Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Pyridine | HCID 1049 | — |
| Reactant | 4-Toluenesulfonyl chloride | HCID 7397 | — |
| Reactant | HCID 21864857 | HCID 21864857 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 131726140 | HCID 131726140 | 17.6% |
Reaction Steps
4-(5-Amino-benzofuran-7-yl)-piperazine-1-carboxylic acid tert-butyl ester (44 mg, 0.139 mmol) in 3 ml dichloromethane was added to a tube containing p-toluenesulfonyl chloride (32 mg, 0.167 mmol) together with pyridine (100 μl, 1.25 mmol) and left on a shaker over weekend. After purification by preparative HPLC, the resulting Boc-material was treated with HCl in ether and left on a shaker until the salt had formed. The solution was centrifugated and the supernatant was removed. Ether was added, then centrifugated and decanted (repeated three times) to remove the excess HCl. The remaining ether was finally evaporated in a SpeedVAc concentrator to yield 10 mg of title product. HPLC purity=94%, m/z=372.3 (M+H). 1H NMR (270 MHz, methanol-d4) δ ppm 2.35 (s, 3 H) 3.45 (m, 8 H) 6.63 (d, J=1.85 Hz, 1 H) 6.71 (d, J=2.11 Hz, 1 H) 6.88 (d, J=1.85 Hz, 1 H) 7.25 (m, 2 H) 7.58 (m, 2 H) 7.71 (d, J=2.11 Hz, 1 H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07144883B2 |
|---|
| Source dataset | uspto-grants-2006_12 |
|---|
| ORD ID | ord-1f8686a072344b79877d8357de089cd7 |
|---|
| Source note | uspto-grants-2006_12 |
|---|